SMALL LYMPHOCYTIC LEUKEMIA
Clinical trials for SMALL LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could early ibrutinib stop CLL before it starts?
Disease control CompletedThis study tested whether giving the drug ibrutinib early to people with chronic lymphocytic leukemia (CLL) who have no symptoms but are at high risk for the disease getting worse could help them achieve remission. Twenty-three participants took ibrutinib for up to 24 months. The…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New drug candidate BR101801 tested in patients with advanced blood cancers
Disease control CompletedThis early-phase trial tested a new drug called BR101801 in 26 adults with advanced blood cancers like lymphoma and leukemia that had not responded to other treatments. The main goals were to find a safe dose and check for side effects. The study was completed, but results are no…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
What happens when CLL drugs stop working? new study investigates
Knowledge-focused CompletedThis study looked at 152 adults with chronic lymphocytic leukemia (CLL) whose cancer stopped responding to targeted drugs like ibrutinib and venetoclax. Researchers collected data on which treatments were used next and how well they worked. The goal was to understand the best way…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC